概要

Embryo Microinjection for Transgenesis in Drosophila

Published: June 07, 2024
doi:

概要

This article takes the phiC31 integrase-mediated transgenesis in Drosophila as an example and presents an optimized protocol for embryo microinjection, a crucial step for creating transgenic flies.

Abstract

Transgenesis in Drosophila is an essential approach to studying gene function at the organism level. Embryo microinjection is a crucial step for the construction of transgenic flies. Microinjection requires some types of equipment, including a microinjector, a micromanipulator, an inverted microscope, and a stereo microscope. Plasmids isolated with a plasmid miniprep kit are qualified for microinjection. Embryos at the pre-blastoderm or syncytial blastoderm stage, where nuclei share a common cytoplasm, are subjected to microinjection. A cell strainer eases the process of dechorionating embryos. The optimal time for dechorionation and desiccation of embryos needs to be determined experimentally. To increase the efficiency of embryo microinjection, needles prepared by a puller need to be beveled by a needle grinder. In the process of grinding needles, we utilize a foot air pump with a pressure gauge to avoid the capillary effect of the needle tip. We routinely inject 120-140 embryos for each plasmid and obtain at least one transgenic line for around 85% of plasmids. This article takes the phiC31 integrase-mediated transgenesis in Drosophila as an example and presents a detailed protocol for embryo microinjection for transgenesis in Drosophila.

Introduction

The fruit fly Drosophila melanogaster is extremely amenable to genetic manipulation and genetic analysis. Transgenic fruit flies are widely used in biological research. Since it was developed in the early 1980s, P-element transposon-mediated transgenesis has been indispensable for Drosophila research1. In some scenarios, other transposons, such as piggyBac and Minos have been used for transgenesis in Drosophila as well2. Transgenes via transposon are randomly inserted into the Drosophila genome, and the expression levels of transgenes at different genomic loci may vary due to position effects and thereby can not be compared2. These drawbacks were overcome by the phiC31-mediated site-specific transgenesis3. The bacteriophage phiC31 gene encodes an integrase that mediates sequence-specific recombination between the attB and attP sites in Drosophila3. Many attP docking sites have been characterized and are available in the Bloomington Drosophila Stock Center3,4,5,6,7,8,9.

The phiC31 transgenesis system for Drosophila has been widely used by the fly community. Among the attP docking sites, attP18 on the X chromosome, attP40 on the second chromosome, and attP2 on the third chromosome are usually the preferred sites for transgene integration on each chromosome because transgenes at the three sites show high levels of inducible expression while having low levels of basal expression5. Recently, however, van der Graaf and colleagues found that the attP40 site, close to the Msp300 gene locus, and transgenes integrated at attP40 cause larval muscle nuclear clustering in Drosophila10. In another recent study, Duan and colleagues found that the homozygous attP40 chromosome disrupts the normal glomerular organization of the Or47b olfactory receptor neuron class in Drosophila11. These findings suggest that rigorous controls should be included when designing experiments and interpreting data.

Drosophila is an ideal model organism for in vivo interrogation of gene function due to its short life cycle, low cost, and easy maintenance. Genome-wide genetic screening relies on the construction of genome-wide transgenic libraries in Drosophila12,13,14,15. We previously generated 5551 UAS-cDNA/ORF constructs based on the binary GAL4/upstream activating sequence (GAL4/UAS) system, covering 83% of the Drosophila genes conserved in humans in the Drosophila Genomics Resource Center (DGRC) Gold Collection16. The UAS-cDNA/ORF plasmids can be used for the creation of a transgenic UAS-cDNA/ORF library in Drosophila. Efficient embryo microinjection technology can accelerate the creation of transgenic fly libraries.

For embryo microinjection, the needle tip is normally broken against a coverslip17. Thereby, needles frequently become clogged or cause leakage of large amounts of cytoplasm, and when these issues arise, new needles must be employed. Although beveling needles can enhance microinjection efficiency, the grinding solution enters the beveled tip during the grinding process. The grinding solution in the beveled tip does not quickly evaporate naturally; therefore, needles can not be utilized for microinjection directly after beveling. These factors reduce the efficiency of embryo microinjection procedures. Here, using the phiC31-mediated site-specific transgenesis in Drosophila as an example, we present a protocol for embryo microinjection for transgenesis in Drosophila. To prevent the grinding solution from entering the needle, we utilize an air pump to exert air pressure within the needle, thereby preventing the grinding solution from entering the beveled tip. Beveled needles are ready for sample loading and microinjection directly after beveling.

Protocol

1. Preparation of plasmids

  1. Isolate plasmids from 4 mL overnight bacterial cultures using a plasmid miniprep kit. Elute with 40 µL of elution buffer.
    NOTE: Isolation of plasmids using a plasmid midi-prep kit is not necessary. A plasmid miniprep kit can fully meet the experimental requirements for embryo microinjection. In this protocol, the prepared UAS-cDNA/ORF plasmids contain ten copies of UAS, an Hsp70 minimal promoter, an attB site, a mini-white gene, and a gene of interest.
  2. Determine the plasmid DNA concentration using a spectrophotometer and store it at -80 °C freezer.
    NOTE: Plasmid concentration is not critical for successful embryo microinjection, as plasmid concentrations ranging from 20 ng/µL to 1683 ng/µL work well for transgenesis in Drosophila (Supplementary Table 1).
  3. Just before microinjection, thaw plasmids and centrifuge at 13000 x g for 5 min.
  4. Transfer 10 µL of each plasmid from the upper layer of the liquid into a new 1.5 mL tube.

2. Pulling needles

  1. Turn on a needle puller with selected settings (Heat: 500, Pull: 50, Vel: 60, Delay: 90, Pressure: 200, Ramp Test: 510).
  2. Insert a borosilicate glass capillary (outer diameter 1.0 mm, inner diameter 0.75 mm, 10 cm length) into the needle puller and close the lid.
  3. Press the Pull button. Each glass capillary makes two needles.

3. Grinding needles (Figure 1)

  1. Use a needle grinder mounted with an appropriate abrasive plate (for 0.7-2.0 µm tip sizes) of a needle grinder.
  2. Wet the cloth (reference wire) with grinding solution (100 mL of distilled water with 0.9 g of NaCl, 1 mL of wetting agent) and fix the cloth.
  3. Turn on the needle grinder and keep the grinding plate rotating.
  4. Connect a needle to a foot air pump with a pressure gauge via a silicone capillary tube, and then mount the needle onto a needle holder of the needle grinder. Adjust the angle of the needle relative to the grinding plate to 35° (Figure 1A, B).
  5. Adjust the position of the needle tip just above the grinding plate surface by using a coarse control knob under the microscope (Figure 1C).
    NOTE: The pulled needles obtained in section 2 have a 6-8 mm taper and a less than 1 µm tip (Figure 1D), as is described in the user manual of the puller.
  6. Keep the inner pressure of the needle at 40 psi using the foot air pump. Adjust the position of the needle tip by using a fine control knob under the microscope, and make the tip of the needle touch the grinding plate.
  7. Grind for 3-5 s. When tiny air bubbles come out of the needle tip, unload the needle (Figure 1E).
    NOTE: In the process of grinding, using an air pump prevents the grinding solution from siphoning.
  8. Put the ground needles into a storage case.
    NOTE: Use freshly ground needles as much as possible, though the ground needles can be kept in a storage case for at least a few weeks before microinjection.

4. Preparing pipettes for loading plasmids

  1. Heat a 200 µL pipette with the outer flame of an alcohol burner.
  2. Once it starts to melt, stretch the pipette.
  3. Cut off the sealed end of the stretched pipette with scissors, and the stretched pipette is then ready to load DNA into a ground needle.
    NOTE: Alternatively, extremely long and fine tips for filling ground needles are commercially available.
  4. Place these pipettes in an autoclaved plastic box.

5. Collecting embryos

  1. Collect flies (vas-phiC31; + ; attP2) expressing phiC31 integrase and bearing the attP2 docking site 3 days after they are hatched from 50 vials and transfer them to a cage (φ 90 mm x 150 mm). Add a little fresh yeast paste to the center of each grape agar plate18.
  2. Prepare 2-4 cages of flies. Keep the cages and plates at 25 °C and change the plates every day for 2-4 days.
    NOTE: This study combined the vas-phiC31 transgene (Stock # 36313, Bloomington Drosophila Stock Center) on the first chromosome and the attP2 transgene (Stock # 36313, Bloomington Drosophila Stock Center) on the third chromosome. The resulting stock (vas-phiC31; + ; attP2) is used in this protocol. Yeast paste needs to be prepared daily, and fresh yeast paste must be fed to the flies. The replaced cages need to be cleared and dried to get rid of the remaining embryos in the cages.
  3. On the day of microinjection, change the cages and plates in the morning. Then, change the plates every 30 min and collect embryos from these plates. Change all the cages and plates at room temperature (RT) and afterward keep the cages and plates at 25 °C.
    NOTE: Some protocols prefer to incubate the cages and plates at 18 °C for egg laying. It depends on the number of embryos one needs for microinjection.

6. Dechorionating embryos

  1. Prepare 30% bleach by mixing 60 mL of bleach (containing active chlorine content of 34-46 g/L) and 140 mL of double distilled water.
  2. Remove the remaining flies on the grape juice agar plates with a brush or forceps, and rinse embryos into a cell strainer with double distilled water.
  3. Dry the cell strainer containing the embryos with tissue paper.
  4. Place it in a Petri dish containing 30% bleach, and swirl the cell strainer by hand or a horizontal shaker for 1.5 min at 60 rpm.
    NOTE: Rinsing is a critical step. If the rinsing time is not long enough, the shell of an embryo will not come off completely. If the rinsing time is too long, it will cause the embryo to become soft and break easily. The cell strainer should be completely submerged in the 30% bleach. Wear a pair of rubber gloves and a lab coat to avoid injuries caused by bleach.
  5. Rinse embryos for 2 min with double distilled water stored in a laboratory plastic wash bottle to remove the residual bleach. Pick the floating embryos for the line-up.

7. Lining up embryos

  1. Cut the solid grape juice agar into long strips using a blade.
    NOTE: Use purple grape juice to make it easier to line up white embryos.
  2. Transfer the embryos onto a long strip using a paintbrush.
  3. Line up around 60 embryos with a dissecting needle along the edge of a long strip with their posteriors facing the outside of the strip. Line up around 60 embryos within 5 min.
    NOTE: The micropyle is a cone-shaped protrusion at the anterior pole of the embryo, through which the sperm enters to fertilize the oocyte (Figure 2A). Therefore, based on the cone-shaped protrusion at the anterior pole of the embryo, it is easy to determine the posterior of the dechorionated embryo.
  4. Place an 18 mm double-sided tape lengthwise along the edge of a coverslip (18 mm x 18 mm) and remove the paper backing. Gently press the coverslip onto the aligned embryos. Ensure the embryos are glued to the center of the tape.

8. Desiccating embryos

  1. Place the coverslip with the lined-up embryos in a box containing desiccant. The drying time varies depending on temperature and humidity.
    NOTE: The drying time is critical for microinjection and needs to be experimentally determined. The drying time is usually 9-10 min in summer and 17-18 min in winter.
  2. Cover the embryos with halocarbon oil.
    NOTE: Do not drop too much oil onto the embryos, as the extra oil may overflow the adhesive. The volume ratio of halocarbon oil 700 and halocarbon oil 27 is 1:3.

9. Microinjecting embryos

  1. Load 2 µL of DNA into the needle by using the stretched pipette. Ensure that there are no bubbles in the needle. Place the needle into the needle holder of the micromanipulator.
  2. Place the aligned embryos covered with halocarbon oil under an inverted microscope. Ensure that the posterior ends of the embryos face the needle.
  3. Use the micromanipulator to bring the needle close to the embryos. Clear the needle. Ensure that a drop of liquid coming out of the needle is visible. Starting from 300 hPa injection pressure and 20 hPa equilibrium pressure, adjust the pressure of injection and the pressure of equilibrium to ensure the optimal size of the drop of liquid.
  4. Use the micromanipulator to insert the needle into the posterior ends of the embryos, and use the foot control connected to the microinjector to inject the DNA (Figure 2). If a small halo is visible, DNA is successfully injected into the embryo.
    NOTE: Select the multinucleate embryos for injection and kill the older embryos using the "clean" button. If a large amount of cytoplasm leaks after injection, embryos are under-dried. If only a small amount of or no amount of cytoplasm leaks after injection, injections are considered successful. If more than one-third of the embryos leak cytoplasm after injection, extend the drying time by 1-2 min. If more than one-third of the embryos are over-dried, shorten the drying time by 1-2 min.
  5. Remove the needle from the embryo. Move the needle to the posterior end of the next embryo. Repeat the above steps.
  6. Put the injected embryos into an agar plate. Place the plate in a room at 18-20 °C. On the next day, transfer the plate to an incubator at a temperature of 25 °C and a humidity of 50%-60%, and incubate for 1 day.
    NOTE: After injection, keep embryos at a temperature of 18-20 °C to slow down their development, facilitate the integration of plasmid DNA into the Drosophila genome, and increase the survival rate of the injected embryos.

10. Collecting larvae

  1. Use a dissecting needle to scrape and loosen the food in a vial. Supply the food with a few drops of distilled water.
    NOTE: Allow the distilled water to be absorbed into the food to prevent larvae from drowning.
  2. Take out the plates from the incubator.
  3. Collect the hatched larvae with a paintbrush under a stereo microscope and transfer them to the vial.
  4. Place the vial into an incubator at a temperature of 25 °C and a humidity of 50%-60%.

11. Obtaining transgenic flies

  1. Collect the hatched flies after the vial is incubated at 25 °C for 10 days.
  2. Cross a single male fly to three virgin female flies of the TM2/TM6C Sb1 Tb1 balancers, and cross a single female fly to three male flies of the TM2/TM6C Sb1 Tb1 balancers.
  3. Place the crosses into an incubator at a temperature of 25 °C and a humidity of 50%-60%.
  4. Screen the progeny for flies with orange eyes. These are the transgenic flies (Figure 3A-C).
    NOTE: Flies bearing a copy of transgene at the attP2 docking site have orange eyes.
  5. Cross a single orange-eyed male fly to three virgin female flies of the TM2/TM6C Sb1 Tb1 balancers to establish a stock.
    NOTE: More than one generation of crosses need to be set up in order to cross out the phiC31 transgene on the first chromosome.

Representative Results

The tip of an injection needle is beveled by a needle grinder (Figure 1). One can bevel 50-60 needles in one hour. DNA is microinjected into the posterior of an embryo at the pre-blastoderm or syncytial blastoderm stage, where nuclei share a common cytoplasm (Figure 2A). The posterior of an embryo can be readily located based on the micropyle at the anterior of the embryo (Figure 2A). Embryos at the cellular blastoderm and gastrulation stages can not be used for injection, as each nucleus is encircled by a cell membrane at these stages, and thereby, the chance of obtaining transgenic flies is almost zero (Figure 2B). Overdried embryos are deformed when punctured and can not be used for microinjection (Figure 2C). Underdried embryos can extrude a large amount of cytoplasm when poked with the needle (Figure 2D), resulting in a lower survival rate of embryos. Embryos that are appropriately dried may or may not leak out a small amount of cytoplasm when injected (Figure 2E).

The Drosophila line expressing phiC31 integrase and bearing the attP2 docking site that is used for embryo microinjection in this protocol has white eyes (Figure 3A), and the aged flies of this genotype have pink eyes resulting from accumulated red fluorescent protein expressed specifically in the eye (Figure 3B). We use the mini-white gene as a selective marker for transgenesis in Drosophila, and transgenic flies are identified by eye color ranging from light yellow to red. Transgenic flies bearing a transgene at the attP2 docking site have orange eyes (Figure 3C), which one can tell readily from flies bearing no transgenes.

Figure 1
Figure 1: Grinding the needles. (A) A foot air pump with a pressure gauge is utilized to apply air pressure to the needle. (B) A needle is mounted on a needle grinder at an angle of 35° to a grinding plate surface. (C) Use a coarse adjustment knob to position the needle tip just above the grinding plate surface, then use a fine adjustment knob to start beveling the tip. (D) The tip of a pulled needle is under a microscope. Scale bars = 10 µm. (E) A beveled needle is under a microscope. The beveled tip of the needle is indicated by an arrow. Scale bars = 10 µm. Please click here to view a larger version of this figure.

Figure 2
Figure 2: Drosophila embryos suitable for microinjection. (A) A Drosophila embryo at the pre-blastoderm or syncytial blastoderm stage can be injected in the posterior pole of the embryo, denoted by a red ellipse. The micropyle at the anterior pole of the embryo is indicated by an arrow. (B) A Drosophila embryo at the cellular blastoderm stage can not be used for microinjection. (C) An embryo that is overdesiccated looks deformed. (D) Insufficient desiccation of an embryo leads to a large amount of cytoplasmic leakage after injection. (E) For a successful injection, a small amount of cytoplasm may leak. Scale bars = 50 µm. Please click here to view a larger version of this figure.

Figure 3
Figure 3: Eye color of transgenic Drosophila bearing a transgene at the attP2 docking site. (A) The attP2 injection line expressing phiC31 integrase (vas-phiC31; + ; attP2) has a white eye. RFP specifically expressed in the eye is used as a selective marker for phiC31 transgene. (B) The aged attP2 injection line expressing phiC31 integrase has a pink eye resulting from the accumulated RFP protein in the eye. (C) Flies bearing a transgene integrated into the attP2 docking site have an orange eye. Scale bars = 100 µm. Please click here to view a larger version of this figure.

Supplementary Table 1: Transgenesis in Drosophila resulting from embryo microinjection of 100 distinct plasmids. A total of 100 distinct plasmids of various concentrations ranging from 20 ng/µL to 1683 ng/µL were injected into embryos, and transgenic flies were obtained for 85 of the 100 plasmids. Please click here to download this File.

Supplementary Table 2: Efficiency of embryo microinjection for transgenesis in Drosophila. A total of 120 distinct plasmids were injected into embryos, and transgenic flies were obtained for 101 of the 120 plasmids. Please click here to download this File.

Discussion

Here, we present a protocol for embryo microinjection for transgenesis in Drosophila. For phiC31-mediated site-specific transgenesis, we injected 120-140 embryos for each plasmid and obtained at least one transgenic line for around 85% of plasmids (Supplementary Table 2). In our experience, plasmid DNA isolated by a plasmid miniprep kit suffices for transgenesis in Drosophila. Plasmid DNA concentrations ranging from 20 ng/µL to 1683 ng/µL might have no apparent effect on the success rate of transgenesis because most of them can produce transgenic flies (Supplementary Table 1).

The preparation of injection needles is critical for efficient embryo microinjection. An Injection needle is closed after it is pulled by a needle puller. For routine phiC31-mediated transgenesis in Drosophila, the tip of a needle is usually broken by a coverslip17. However, the randomly broken needles are often not well-suited for embryo microinjection, as they may get blocked or cause leakage of a large amount of cytoplasm and thereby have to be replaced by a new one during injection. Injection needles whose tips are beveled by a grinder do not usually get blocked or elicit large cytoplasmic leakage, which reduces the frequency of needle replacement. We noticed that the grinding solution can enter the beveled tip of a needle once the tip is open during grinding. Once it enters the needle, the grinding solution will not quickly dry up naturally. To prevent the grinding solution from siphoning, we connect an injection needle to a foot air pump with a pressure gauge. While grinding the tip of the needle, we use the air pump to apply air pressure to the needle, and thereby, the grinding solution is prevented from entering the beveled tip, enabling the beveled needle to be used immediately. Together, the foot air pump with the pressure gauge should help to accelerate transgenesis in Drosophila, particularly for a large of number of plasmids.

Identifying embryos at the pre-blastoderm or syncytial blastoderm stage is critical for microinjection19,20, as injecting embryos at later stages barely produces transgenic flies. Flies less than 10 days old are used for egg laying as they tend to lay more eggs than older ones. In the process of dechorionating embryos, a cell strainer is utilized to simplify the bleach treatment and double distilled water rinsing of embryos. After embryo rinsing, the floating embryos indicate that the eggshells have been well treated and can be used for subsequent microinjection. Both the dechorionation and drying time of embryos are critical for microinjection and should be optimized experimentally, as prolonged dechorionation or drying time can kill embryos. The dechorionation and drying time are affected by the temperature and humidity that vary from place to place and from time to time and should be adjusted accordingly based on the embryonic hatching rate.

開示

The authors have nothing to disclose.

Acknowledgements

The work was supported by the Scientific Research Fund for High-Level Talents, University of South China.

Materials

100 μm Cell Strainer NEST 258367
3M double-sided adhesive 3M 415
Borosilicate glass SUTTER B100-75-10
Diamond abrasive plate SUTTER 104E
FLAMING/BROWN Micropipette Puller SUTTER P-1000
Foot air pump with pressure gauge Shenfeng SF8705D
Halocarbon oil 27 Sigma H8773
Halocarbon oil 700 Sigma H8898
Inverted microscope Nikon ECLIPSE Ts2R
Microinjection pump eppendorf FemtoJet 4i
Micromanipulator eppendorf TransferMan 4r
Micropipette Beveler SUTTER BV-10
Microscope cover glasses (18 mm x 18 mm) CITOLAS 10211818C
Microscope slides (25 mm x 75 mm) CITOLAS 188105W
Petri dish (90 mm x 15 mm) LAIBOER 4190152
Photo-Flo 200 Kodak 1026269
QIAprep Spin Miniprep Kit Qiagen 27106
Stereo Microscope Nikon SMZ745

参考文献

  1. Rubin, G. M., Spradling, A. C. Genetic transformation of Drosophila with transposable element vectors. Science. 218 (4570), 348-353 (1982).
  2. Venken, K. J., Bellen, H. J. Transgenesis upgrades for Drosophila melanogaster. Development. 134 (20), 3571-3584 (2007).
  3. Groth, A. C., Fish, M., Nusse, R., Calos, M. P. Construction of transgenic Drosophila by using the site-specific integrase from phage phic31. 遺伝学. 166 (4), 1775-1782 (2004).
  4. Bischof, J., Maeda, R. K., Hediger, M., Karch, F., Basler, K. An optimized transgenesis system for Drosophila using germ-line-specific phic31 integrases. Proc Natl Acad Sci U S A. 104 (9), 3312-3317 (2007).
  5. Markstein, M., Pitsouli, C., Villalta, C., Celniker, S. E., Perrimon, N. Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes. Nat Genet. 40 (4), 476-483 (2008).
  6. Bateman, J. R., Lee, A. M., Wu, C. T. Site-specific transformation of Drosophila via phic31 integrase-mediated cassette exchange. 遺伝学. 173 (2), 769-777 (2006).
  7. Venken, K. J., He, Y., Hoskins, R. A., Bellen, H. J. P[acman]: A BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster. Science. 314 (5806), 1747-1751 (2006).
  8. Szabad, J., Bellen, H. J., Venken, K. J. An assay to detect in vivo Y chromosome loss in Drosophila wing disc cells. G3. 2 (9), 1095-1102 (2012).
  9. Ringrose, L. Transgenesis in Drosophila melanogaster. Methods Mol Biol. 561, 3-19 (2009).
  10. Van Der Graaf, K., Srivastav, S., Singh, P., Mcnew, J. A., Stern, M. The Drosophila melanogaster attp40 docking site and derivatives are insertion mutations of msp-300. PLoS One. 17 (12), e0278598 (2022).
  11. Duan, Q., Estrella, R., Carson, A., Chen, Y., Volkan, P. C. The effect of Drosophila attp40 background on the glomerular organization of or47b olfactory receptor neurons. G3. 13 (4), 022 (2023).
  12. Dietzl, G., et al. A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila. Nature. 448 (7150), 151-156 (2007).
  13. Pfeiffer, B. D., et al. Tools for neuroanatomy and neurogenetics in Drosophila. Proc Natl Acad Sci U S A. 105 (28), 9715-9720 (2008).
  14. Bellen, H. J., et al. The Drosophila gene disruption project: Progress using transposons with distinctive site specificities. 遺伝学. 188 (3), 731-743 (2011).
  15. Zirin, J., et al. Large-scale transgenic drosophila resource collections for loss- and gain-of-function studies. 遺伝学. 214 (4), 755-767 (2020).
  16. Wei, P., Xue, W., Zhao, Y., Ning, G., Wang, J. CRISPR-based modular assembly of a UAS-cDNA/ORF plasmid library for more than 5500 Drosophila genes conserved in humans. Genome Res. 30 (1), 95-106 (2020).
  17. Fish, M. P., Groth, A. C., Calos, M. P., Nusse, R. Creating transgenic Drosophila by microinjecting the site-specific phic31 integrase mRNA and a transgene-containing donor plasmid. Nat Protoc. 2 (10), 2325-2331 (2007).
  18. Fujioka, M., Jaynes, J. B., Bejsovec, A., Weir, M. Production of transgenic Drosophila. Methods Mol Biol. 136, 353-363 (2000).
  19. Loncar, D., Singer, S. J. Cell membrane formation during the cellularization of the syncytial blastoderm of Drosophila. Proc Natl Acad Sci U S A. 92 (6), 2199-2203 (1995).
  20. Carmo, C., Araujo, M., Oliveira, R. A. Microinjection techniques in fly embryos to study the function and dynamics of SMC complexes. Methods Mol Biol. 2004, 251-268 (2019).

Play Video

記事を引用
Chen, G., Zhang, X., Xu, S., Zhou, X., Xue, W., Liu, X., Yan, J., Zhang, N., Wang, J. Embryo Microinjection for Transgenesis in Drosophila. J. Vis. Exp. (208), e66679, doi:10.3791/66679 (2024).

View Video